James Patrick Tursi - Dec 1, 2023 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role
Director
Signature
/s/ Phillip D. Torrence, by Power of Attorney
Stock symbol
NRBO
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/4/2023, 05:12 PM
Previous filing
Nov 2, 2023
Next filing
Jun 7, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRBO Common Stock Award $0 +25K $0.00 25K Dec 1, 2023 Direct F1, F2
transaction NRBO Common Stock Award $0 +7.16K +28.63% $0.00 32.2K Dec 1, 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
F2 50% of the RSUs immediately vested on the grant date, and the remainder will vest in two equal installments on each subsequent anniversary of the grant date, subject to continuing service.
F3 Vests on the earlier of December 1, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.